Skip to main content

Table 5 Economic analysis

From: A prospective cohort study: platelet-rich plasma combined with carpal tunnel release treating carpal tunnel syndrome

 

Control Group

N = 39

PRP Group

N = 43

P

*Significant

Hospitalization (Days)

3.56 ± 0.59

3.46 ± 0.54

0.437

Cost (CNY)

12,363.2 ± 901.2

16,206.4 ± 1131.0

 < 0.001*

  1. CNY China Yuan
  2. *Represents a statistical difference between two groups (p < 0.05)
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us